{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T20:28:55Z","timestamp":1782160135157,"version":"3.54.5"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["NO. 81972568"],"award-info":[{"award-number":["NO. 81972568"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cholesterol plays a significant role in stabilizing lipid or membrane rafts, which are specific cellular membrane structures. Cholesterol is involved in numerous cellular processes, including regulating virus entry into the host cell. Multiple viruses have been shown to rely on cholesterol for virus entry and\/or morphogenesis. Research indicates that reprogramming of the host\u2019s lipid metabolism is associated with hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in the progression to severe liver disease for viruses that cause chronic hepatitis. Moreover, knowing the precise mode of viral interaction with target cells sheds light on viral pathogenesis and aids in the development of vaccines and therapeutic targets. As a result, the area of cholesterol-lowering therapy is quickly evolving and has many novel antiviral targets and medications. It has been shown that microRNAs (miRNAs) either directly or indirectly target the viral genome, preventing viral replication. Moreover, miRNAs have recently been shown to be strong post-transcriptional regulators of the genes involved in lipid metabolism, particularly those involved in cholesterol homeostasis. As important regulators of lipid homeostasis in several viral infections, miRNAs have recently come to light. In addition, multiple studies demonstrated that during viral infection, miRNAs modulate several enzymes in the mevalonate\/cholesterol pathway. As cholesterol metabolism is essential to the life cycle of viral hepatitis and other viruses, a sophisticated understanding of miRNA regulation may contribute to the development of a novel anti-HCV treatment. The mechanisms underlying the effectiveness of miRNAs as cholesterol regulators against viral hepatitis are explored in this review.\n<\/jats:p>\n                <jats:p><jats:bold>Graphical Abstract<\/jats:bold><\/jats:p>","DOI":"10.1186\/s12964-023-01250-w","type":"journal-article","created":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T14:40:19Z","timestamp":1694702419000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["The roles of different microRNAs in the regulation of cholesterol in viral hepatitis"],"prefix":"10.1186","volume":"21","author":[{"given":"Xuan","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeganeh","family":"Eslami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Derafsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwar","family":"Saihood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikoo","family":"Emtiazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saman","family":"Yasamineh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Gholizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzon Daniel Cosme","family":"Pecho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,14]]},"reference":[{"issue":"2","key":"1250_CR1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s42255-020-0174-0","volume":"2","author":"B Huang","year":"2020","unstructured":"Huang B, Song B-l, Xu C. Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities. Nat metabolism. 2020;2(2):132\u201341.","journal-title":"Nat metabolism"},{"key":"1250_CR2","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s40279-017-0698-y","volume":"47","author":"DR Hooper","year":"2017","unstructured":"Hooper DR, et al. Endocrinological roles for testosterone in resistance exercise responses and adaptations. Sports Med. 2017;47:1709\u201320.","journal-title":"Sports Med"},{"key":"1250_CR3","doi-asserted-by":"crossref","first-page":"109651","DOI":"10.1016\/j.intimp.2022.109651","volume":"115","author":"H Zeng","year":"2023","unstructured":"Zeng H, et al. Cholesterol and C-reactive protein prognostic score predicted prognosis of immune checkpoint inhibitors based interventional therapies for intermediate-to-advanced hepatocellular carcinoma patients. Int Immunopharmacol. 2023;115:109651.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"1250_CR4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/22221751.2021.2020598","volume":"11","author":"S Kummer","year":"2022","unstructured":"Kummer S, et al. Pharmacologically induced endolysosomal cholesterol imbalance through clinically licensed drugs itraconazole and fluoxetine impairs Ebola virus infection in vitro. Emerg Microbes Infections. 2022;11(1):195\u2013207.","journal-title":"Emerg Microbes Infections"},{"issue":"24","key":"1250_CR5","doi-asserted-by":"crossref","first-page":"11181","DOI":"10.1128\/JVI.01053-16","volume":"90","author":"F Elgner","year":"2016","unstructured":"Elgner F, et al. The intracellular cholesterol transport inhibitor U18666A inhibits the exosome-dependent release of mature hepatitis C virus. J Virol. 2016;90(24):11181\u201396.","journal-title":"J Virol"},{"key":"1250_CR6","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.antiviral.2017.07.022","volume":"145","author":"T Takano","year":"2017","unstructured":"Takano T, et al. The cholesterol transport inhibitor U18666A inhibits type I feline coronavirus infection. Antiviral Res. 2017;145:96\u2013102.","journal-title":"Antiviral Res"},{"issue":"7","key":"1250_CR7","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.3390\/v14071539","volume":"14","author":"B Song","year":"2022","unstructured":"Song B. The cholesterol transport inhibitor U18666A interferes with Pseudorabies Virus infection. Viruses. 2022;14(7):1539.","journal-title":"Viruses"},{"issue":"9","key":"1250_CR8","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.biochi.2013.05.019","volume":"95","author":"S Chapuy-Regaud","year":"2013","unstructured":"Chapuy-Regaud S, et al. Progesterone and a phospholipase inhibitor increase the endosomal bis (monoacylglycero) phosphate content and block HIV viral particle intercellular transmission. Biochimie. 2013;95(9):1677\u201388.","journal-title":"Biochimie"},{"issue":"2","key":"1250_CR9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11427-021-1929-y","volume":"65","author":"G Li","year":"2022","unstructured":"Li G, et al. NPC1-regulated dynamic of clathrin-coated pits is essential for viral entry. Sci China Life Sci. 2022;65(2):341\u201361.","journal-title":"Sci China Life Sci"},{"issue":"1","key":"1250_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-03316-5","volume":"7","author":"S Wichit","year":"2017","unstructured":"Wichit S, et al. Imipramine inhibits chikungunya virus replication in human skin fibroblasts through interference with intracellular cholesterol trafficking. Sci Rep. 2017;7(1):1\u201312.","journal-title":"Sci Rep"},{"issue":"13","key":"1250_CR11","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1128\/JVI.00117-08","volume":"82","author":"C-J Lee","year":"2008","unstructured":"Lee C-J, et al. Cholesterol effectively blocks entry of flavivirus. J Virol. 2008;82(13):6470\u201380.","journal-title":"J Virol"},{"key":"1250_CR12","doi-asserted-by":"crossref","unstructured":"Barrantes FJ. The constellation of cholesterol-dependent processes associated with SARS-CoV-2 infection. Prog Lipid Res. 2022;101166.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/35513161\/.","DOI":"10.1016\/j.plipres.2022.101166"},{"issue":"7","key":"1250_CR13","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3390\/v12070703","volume":"12","author":"S Schloer","year":"2020","unstructured":"Schloer S, et al. Combinatory treatment with oseltamivir and itraconazole targeting both virus and host factors in influenza a virus infection. Viruses. 2020;12(7):703.","journal-title":"Viruses"},{"issue":"5","key":"1250_CR14","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3390\/v5051292","volume":"5","author":"DJ Felmlee","year":"2013","unstructured":"Felmlee DJ, et al. Hepatitis C virus, cholesterol and lipoproteins\u2014impact for the viral life cycle and pathogenesis of liver disease. Viruses. 2013;5(5):1292\u2013324.","journal-title":"Viruses"},{"issue":"12","key":"1250_CR15","doi-asserted-by":"crossref","first-page":"5715","DOI":"10.1128\/JVI.02530-07","volume":"82","author":"H Aizaki","year":"2008","unstructured":"Aizaki H, et al. Critical role of virion-associated cholesterol and sphingolipid in hepatitis C virus infection. J Virol. 2008;82(12):5715\u201324.","journal-title":"J Virol"},{"issue":"7","key":"1250_CR16","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.3390\/ijms23073897","volume":"23","author":"J-W Liou","year":"2022","unstructured":"Liou J-W, Mani H, Yen J-H. Viral Hepatitis, cholesterol metabolism, and cholesterol-lowering natural compounds. Int J Mol Sci. 2022;23(7):3897.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"1250_CR17","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.tem.2010.08.008","volume":"21","author":"KJ Moore","year":"2010","unstructured":"Moore KJ, et al. microRNAs and cholesterol metabolism. Trends in Endocrinology & Metabolism. 2010;21(12):699\u2013706.","journal-title":"Trends in Endocrinology & Metabolism"},{"key":"1250_CR18","doi-asserted-by":"crossref","first-page":"110007","DOI":"10.1016\/j.msec.2019.110007","volume":"104","author":"M Norouzi","year":"2019","unstructured":"Norouzi M, et al. Recent advances on nanomaterials-based fluorimetric approaches for microRNAs detection. Mater Sci Engineering: C. 2019;104:110007.","journal-title":"Mater Sci Engineering: C"},{"key":"1250_CR19","doi-asserted-by":"crossref","unstructured":"Desrochers GF et al. microRNA-27b regulates hepatic lipase enzyme LIPC and reduces triglyceride degradation during hepatitis C virus infection. J Biol Chem. 2022;298(6).\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/35483451\/.","DOI":"10.1016\/j.jbc.2022.101983"},{"key":"1250_CR20","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1007\/s00705-021-05152-5","volume":"166","author":"J Hu","year":"2021","unstructured":"Hu J, et al. The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection. Arch Virol. 2021;166:2649\u201372.","journal-title":"Arch Virol"},{"issue":"12","key":"1250_CR21","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/j.bbalip.2016.01.005","volume":"1861","author":"T-I Jeon","year":"2016","unstructured":"Jeon T-I, Osborne TF. miRNA and cholesterol homeostasis Biochimica et Biophysica Acta (BBA). Mol Cell Biol Lipids. 2016;1861(12):2041\u20136.","journal-title":"Mol Cell Biol Lipids"},{"issue":"11","key":"1250_CR22","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.4161\/15384047.2014.955442","volume":"15","author":"SL Romero-Cordoba","year":"2014","unstructured":"Romero-Cordoba SL, et al. miRNA biogenesis: biological impact in the development of cancer. Cancer Biol Ther. 2014;15(11):1444\u201355.","journal-title":"Cancer Biol Ther"},{"key":"1250_CR23","doi-asserted-by":"crossref","unstructured":"Vishnoi A, Rani S. MiRNA biogenesis and regulation of diseases: an overview. MicroRNA Profiling. 2017. p.\u00a01\u201310.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/27826912\/.","DOI":"10.1007\/978-1-4939-6524-3_1"},{"issue":"12","key":"1250_CR24","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1080\/15476286.2021.1899491","volume":"18","author":"M Li","year":"2021","unstructured":"Li M, Yu B. Recent advances in the regulation of plant miRNA biogenesis. RNA Biol. 2021;18(12):2087\u201396.","journal-title":"RNA Biol"},{"key":"1250_CR25","doi-asserted-by":"crossref","unstructured":"Leit\u00e3o AL, Enguita FJ. A structural view of miRNA Biogenesis and function. Volume 8. Non-coding RNA; 2022. p. 10. 1.","DOI":"10.3390\/ncrna8010010"},{"issue":"10","key":"1250_CR26","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1007\/s00705-021-05152-5","volume":"166","author":"J Hu","year":"2021","unstructured":"Hu J, et al. The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection. Arch Virol. 2021;166(10):2649\u201372.","journal-title":"Arch Virol"},{"issue":"1","key":"1250_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-022-01017-9","volume":"21","author":"E Oveili","year":"2023","unstructured":"Oveili E, et al. The potential use of mesenchymal stem cells-derived exosomes as microRNAs delivery systems in different diseases. Cell Communication and Signaling. 2023;21(1):1\u201326.","journal-title":"Cell Communication and Signaling"},{"key":"1250_CR28","doi-asserted-by":"crossref","unstructured":"Lee Y, et al. Antisense-oligonucleotide co-micelles with tumor targeting peptides elicit therapeutic effects by inhibiting microRNA-21 in the glioblastoma animal models. Journal of Advanced Research; 2023.","DOI":"10.1016\/j.jare.2023.01.005"},{"issue":"9","key":"1250_CR29","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1093\/nar\/gkm024","volume":"35","author":"J Kr\u00fctzfeldt","year":"2007","unstructured":"Kr\u00fctzfeldt J, et al. Specificity, duplex degradation and subcellular localization of antagomirs. Nucleic Acids Res. 2007;35(9):2885\u201392.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1250_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s11658-022-00317-9","volume":"27","author":"A Letafati","year":"2022","unstructured":"Letafati A, et al. MicroRNA let-7 and viral infections: focus on mechanisms of action. Cell Mol Biol Lett. 2022;27(1):1\u201347.","journal-title":"Cell Mol Biol Lett"},{"issue":"6","key":"1250_CR31","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3390\/cells8060611","volume":"8","author":"FSY Yoshikawa","year":"2019","unstructured":"Yoshikawa FSY, et al. Delivery of microRNAs by extracellular vesicles in viral infections: could the news be packaged? Cells. 2019;8(6):611.","journal-title":"Cells"},{"key":"1250_CR32","doi-asserted-by":"crossref","unstructured":"Zheng B, Zhou J, Wang H. Host microRNAs and exosomes that modulate influenza virus infection. Virus Res. 2020;279:197885.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/31981772\/.","DOI":"10.1016\/j.virusres.2020.197885"},{"issue":"1","key":"1250_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41544-018-0004-7","volume":"1","author":"SA Leon-Icaza","year":"2019","unstructured":"Leon-Icaza SA, Zeng M, Rosas-Taraco AG. microRNAs in viral acute respiratory infections: immune regulation, biomarkers, therapy, and vaccines. ExRNA. 2019;1(1):1\u20137.","journal-title":"ExRNA"},{"issue":"1","key":"1250_CR34","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.molmed.2016.11.003","volume":"23","author":"DW Trobaugh","year":"2017","unstructured":"Trobaugh DW, Klimstra WB. MicroRNA regulation of RNA virus replication and pathogenesis. Trends Mol Med. 2017;23(1):80\u201393.","journal-title":"Trends Mol Med"},{"issue":"7","key":"1250_CR35","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.3390\/cells10071762","volume":"10","author":"F Meng","year":"2021","unstructured":"Meng F, et al. Viral microRNAs encoded by nucleocapsid gene of SARS-CoV-2 are detected during infection, and targeting metabolic pathways in host cells. Cells. 2021;10(7):1762.","journal-title":"Cells"},{"issue":"2","key":"1250_CR36","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3390\/cancers12020358","volume":"12","author":"A Gallo","year":"2020","unstructured":"Gallo A, et al. Viral miRNAs as active players and participants in tumorigenesis. Cancers. 2020;12(2):358.","journal-title":"Cancers"},{"issue":"12","key":"1250_CR37","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1002\/ijc.31595","volume":"143","author":"X Song","year":"2018","unstructured":"Song X, et al. HBV suppresses ZHX2 expression to promote proliferation of HCC through miR-155 activation. Int J Cancer. 2018;143(12):3120\u201330.","journal-title":"Int J Cancer"},{"issue":"3","key":"1250_CR38","doi-asserted-by":"crossref","first-page":"e92998","DOI":"10.1371\/journal.pone.0092998","volume":"9","author":"F Peng","year":"2014","unstructured":"Peng F, et al. HBx down-regulated Gld2 plays a critical role in HBV-related dysregulation of miR-122. PLoS ONE. 2014;9(3):e92998.","journal-title":"PLoS ONE"},{"key":"1250_CR39","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00705-021-04952-z","volume":"166","author":"L Mo","year":"2021","unstructured":"Mo L, et al. Hepatitis A virus-induced hsa-miR-146a-5p attenuates IFN-\u03b2 signaling by targeting adaptor protein TRAF6. Arch Virol. 2021;166:789\u201399.","journal-title":"Arch Virol"},{"key":"1250_CR40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.coviro.2014.03.005","volume":"7","author":"JA Wilson","year":"2014","unstructured":"Wilson JA, Sagan SM. Hepatitis C virus and human miR-122: insights from the bench to the clinic. Curr Opin Virol. 2014;7:11\u20138.","journal-title":"Curr Opin Virol"},{"issue":"3","key":"1250_CR41","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jhep.2008.06.010","volume":"50","author":"Y Murakami","year":"2009","unstructured":"Murakami Y, et al. Regulation of the hepatitis C virus genome replication by miR-199a. J Hepatol. 2009;50(3):453\u201360.","journal-title":"J Hepatol"},{"issue":"19","key":"1250_CR42","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1016\/j.jmb.2020.07.015","volume":"432","author":"RN Patil","year":"2020","unstructured":"Patil RN, Karpe YA. Uncovering the roles of miR-214 in hepatitis E virus replication. J Mol Biol. 2020;432(19):5322\u201342.","journal-title":"J Mol Biol"},{"key":"1250_CR43","unstructured":"McDonald JT, et al. Role of miR-2392 in driving SARS-CoV-2 infection. Cell Rep. 2021;37(3):109839.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/34624208\/."},{"key":"1250_CR44","doi-asserted-by":"crossref","unstructured":"Chiang K, Liu H, Rice AP. miR-132 enhances HIV-1 replication. Virology. 2013;438(1):1\u20134.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3594373\/.","DOI":"10.1016\/j.virol.2012.12.016"},{"issue":"4","key":"1250_CR45","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S2055-6640(20)30322-8","volume":"3","author":"G Frattari","year":"2017","unstructured":"Frattari G, Aagaard L, Denton PW. The role of miR-29a in HIV-1 replication and latency. J virus eradication. 2017;3(4):185\u201391.","journal-title":"J virus eradication"},{"issue":"6","key":"1250_CR46","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jinf.2014.12.001","volume":"70","author":"W Wen","year":"2015","unstructured":"Wen W, et al. Cellular microRNA-miR-548\u00a0g-3p modulates the replication of dengue virus. J Infect. 2015;70(6):631\u201340.","journal-title":"J Infect"},{"key":"1250_CR47","doi-asserted-by":"crossref","unstructured":"Kanokudom S, et al. miR-21 promotes dengue virus serotype 2 replication in HepG2 cells. Antiviral Res. 2017;142:169\u201377.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/28365456\/.","DOI":"10.1016\/j.antiviral.2017.03.020"},{"key":"1250_CR48","doi-asserted-by":"crossref","unstructured":"Assefi M et al. Potential use of the cholesterol transfer inhibitor U18666A as an antiviral drug for research on various viral infections Microbial Pathogenesis, 2023: p.\u00a0106096.","DOI":"10.1016\/j.micpath.2023.106096"},{"issue":"2","key":"1250_CR49","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1462-5822.2008.01250.x","volume":"11","author":"CM Bremer","year":"2009","unstructured":"Bremer CM, et al. Hepatitis B virus infection is dependent on cholesterol in the viral envelope. Cell Microbiol. 2009;11(2):249\u201360.","journal-title":"Cell Microbiol"},{"issue":"1","key":"1250_CR50","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.virol.2009.10.019","volume":"396","author":"I Ceballos-Olvera","year":"2010","unstructured":"Ceballos-Olvera I, et al. JNK phosphorylation, induced during dengue virus infection, is important for viral infection and requires the presence of cholesterol. Virology. 2010;396(1):30\u20136.","journal-title":"Virology"},{"issue":"10","key":"1250_CR51","doi-asserted-by":"crossref","first-page":"2200111","DOI":"10.1002\/bies.202200111","volume":"44","author":"A Lu","year":"2022","unstructured":"Lu A. Endolysosomal cholesterol export: more than just NPC1. BioEssays. 2022;44(10):2200111.","journal-title":"BioEssays"},{"issue":"16","key":"1250_CR52","doi-asserted-by":"crossref","first-page":"7982","DOI":"10.1128\/JVI.00259-09","volume":"83","author":"Y Tang","year":"2009","unstructured":"Tang Y, et al. Deficiency of niemann-pick type C-1 protein impairs release of human immunodeficiency virus type 1 and results in gag accumulation in late endosomal\/lysosomal compartments. J Virol. 2009;83(16):7982\u201395.","journal-title":"J Virol"},{"issue":"7364","key":"1250_CR53","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature10380","volume":"477","author":"M C\u00f4t\u00e9","year":"2011","unstructured":"C\u00f4t\u00e9 M, et al. Small molecule inhibitors reveal Niemann\u2013Pick C1 is essential for Ebola virus infection. Nature. 2011;477(7364):344\u20138.","journal-title":"Nature"},{"issue":"4","key":"1250_CR54","first-page":"e00917","volume":"10","author":"Y Fan","year":"2022","unstructured":"Fan Y, et al. The NPC families mediate BmNPV Entry. Microbiol Spectr. 2022;10(4):e00917\u201322.","journal-title":"Microbiol Spectr"},{"issue":"3","key":"1250_CR55","first-page":"e00677","volume":"13","author":"Q Wei","year":"2022","unstructured":"Wei Q, et al. Dual-role of cholesterol-25\u2010Hydroxylase in regulating Hepatitis B Virus infection and replication. Mbio. 2022;13(3):e00677\u201322.","journal-title":"Mbio"},{"issue":"1","key":"1250_CR56","doi-asserted-by":"crossref","first-page":"7242","DOI":"10.1038\/srep07242","volume":"4","author":"Y Chen","year":"2014","unstructured":"Chen Y, et al. Interferon-inducible cholesterol-25-hydroxylase inhibits hepatitis C virus replication via distinct mechanisms. Sci Rep. 2014;4(1):7242.","journal-title":"Sci Rep"},{"issue":"1","key":"1250_CR57","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.immuni.2012.11.005","volume":"38","author":"S-Y Liu","year":"2013","unstructured":"Liu S-Y, et al. Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol. Immunity. 2013;38(1):92\u2013105.","journal-title":"Immunity"},{"issue":"11","key":"1250_CR58","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/s41422-020-00398-1","volume":"30","author":"S Zu","year":"2020","unstructured":"Zu S, et al. 25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor. Cell Res. 2020;30(11):1043\u20135.","journal-title":"Cell Res"},{"issue":"3","key":"1250_CR59","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.immuni.2017.02.012","volume":"46","author":"C Li","year":"2017","unstructured":"Li C, et al. 25-Hydroxycholesterol protects host against Zika virus infection and its associated microcephaly in a mouse model. Immunity. 2017;46(3):446\u201356.","journal-title":"Immunity"},{"issue":"6","key":"1250_CR60","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0014-4835(79)90068-X","volume":"28","author":"RJ Cenedella","year":"1979","unstructured":"Cenedella RJ, Bierkamper GG. Mechanism of cataract production by 3-\u03b2 (2-diethylaminoethoxy) androst-5-en-17-one hydrochloride, U18666A: an inhibitor of cholesterol biosynthesis. Exp Eye Res. 1979;28(6):673\u201388.","journal-title":"Exp Eye Res"},{"issue":"1","key":"1250_CR61","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.antiviral.2011.11.014","volume":"93","author":"MK Poh","year":"2012","unstructured":"Poh MK, et al. U18666A, an intra-cellular cholesterol transport inhibitor, inhibits dengue virus entry and replication. Antiviral Res. 2012;93(1):191\u20138.","journal-title":"Antiviral Res"},{"issue":"3","key":"1250_CR62","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jhep.2010.12.011","volume":"55","author":"T Takano","year":"2011","unstructured":"Takano T, et al. Augmentation of DHCR24 expression by hepatitis C virus infection facilitates viral replication in hepatocytes. J Hepatol. 2011;55(3):512\u201321.","journal-title":"J Hepatol"},{"issue":"1","key":"1250_CR63","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41392-022-01125-5","volume":"7","author":"Y Duan","year":"2022","unstructured":"Duan Y, et al. Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics. Signal Transduct Target Therapy. 2022;7(1):265.","journal-title":"Signal Transduct Target Therapy"},{"issue":"1","key":"1250_CR64","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/nyas.14566","volume":"1495","author":"KM Citrin","year":"2021","unstructured":"Citrin KM, Fern\u00e1ndez-Hernando C, Su\u00e1rez Y. MicroRNA regulation of cholesterol metabolism. Ann N Y Acad Sci. 2021;1495(1):55\u201377.","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"1250_CR65","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.bbalip.2016.03.007","volume":"1861","author":"L Goedeke","year":"2016","unstructured":"Goedeke L, et al. miRNA regulation of LDL-cholesterol metabolism Biochimica et Biophysica Acta (BBA). Mol Cell Biol Lipids. 2016;1861(12):2047\u201352.","journal-title":"Mol Cell Biol Lipids"},{"issue":"1","key":"1250_CR66","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1038\/ncomms7498","volume":"6","author":"J Miao","year":"2015","unstructured":"Miao J, et al. Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis. Nat Commun. 2015;6(1):6498.","journal-title":"Nat Commun"},{"issue":"1","key":"1250_CR67","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cmet.2013.06.010","volume":"18","author":"T-I Jeon","year":"2013","unstructured":"Jeon T-I, et al. An SREBP-responsive microRNA operon contributes to a regulatory loop for intracellular lipid homeostasis. Cell Metabol. 2013;18(1):51\u201361.","journal-title":"Cell Metabol"},{"key":"1250_CR68","doi-asserted-by":"crossref","unstructured":"Choi SE, et al. Elevated micro RNA-34a in obesity reduces NAD + levels and SIRT 1 activity by directly targeting NAMPT. Aging Cell. 2013;12(6):1062\u201372.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/23834033\/.","DOI":"10.1111\/acel.12135"},{"key":"1250_CR69","doi-asserted-by":"crossref","unstructured":"Najafi-Shoushtari SH, et al. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science. 2010;328(5985):1566\u20139.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/20466882\/.","DOI":"10.1126\/science.1189123"},{"issue":"7","key":"1250_CR70","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/nm.3200","volume":"19","author":"J Soh","year":"2013","unstructured":"Soh J, et al. MicroRNA-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion. Nat Med. 2013;19(7):892\u2013900.","journal-title":"Nat Med"},{"issue":"9","key":"1250_CR71","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.2337\/db13-1015","volume":"63","author":"CL Kurtz","year":"2014","unstructured":"Kurtz CL, et al. MicroRNA-29 fine-tunes the expression of key FOXA2-activated lipid metabolism genes and is dysregulated in animal models of insulin resistance and diabetes. Diabetes. 2014;63(9):3141\u20138.","journal-title":"Diabetes"},{"issue":"12","key":"1250_CR72","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.3390\/jcm8122199","volume":"8","author":"EL Solly","year":"2019","unstructured":"Solly EL, et al. MicroRNAs as therapeutic targets and clinical biomarkers in atherosclerosis. J Clin Med. 2019;8(12):2199.","journal-title":"J Clin Med"},{"issue":"1","key":"1250_CR73","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/CIRCRESAHA.114.300645","volume":"114","author":"KJ Rayner","year":"2014","unstructured":"Rayner KJ, Moore KJ. MicroRNA control of high-density lipoprotein metabolism and function. Circul Res. 2014;114(1):183\u201392.","journal-title":"Circul Res"},{"key":"1250_CR74","doi-asserted-by":"crossref","unstructured":"Gholizadeh O et al. The role of non-coding RNAs in the diagnosis of different stages (HCC, CHB, OBI) of hepatitis B infection Microbial Pathogenesis, 2023: p.\u00a0105995.","DOI":"10.1016\/j.micpath.2023.105995"},{"key":"1250_CR75","doi-asserted-by":"crossref","unstructured":"Gholizadeh O et al. Hepatitis A: Viral Structure, Classification, Life Cycle, Clinical Symptoms, Diagnosis Error, and Vaccination Canadian Journal of Infectious Diseases and Medical Microbiology, 2023. 2023.","DOI":"10.1155\/2023\/4263309"},{"issue":"1","key":"1250_CR76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-09588-w","volume":"12","author":"DA Sheridan","year":"2022","unstructured":"Sheridan DA, et al. Infection with the hepatitis C virus causes viral genotype-specific differences in cholesterol metabolism and hepatic steatosis. Sci Rep. 2022;12(1):1\u201311.","journal-title":"Sci Rep"},{"issue":"1","key":"1250_CR77","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/hep.26634","volume":"59","author":"R Singaravelu","year":"2014","unstructured":"Singaravelu R, et al. Hepatitis C virus induced up-regulation of microRNA\u201027: a novel mechanism for hepatic steatosis. Hepatology. 2014;59(1):98\u2013108.","journal-title":"Hepatology"},{"issue":"6","key":"1250_CR78","doi-asserted-by":"crossref","first-page":"e01500","DOI":"10.1128\/mBio.01500-15","volume":"6","author":"SR Selitsky","year":"2015","unstructured":"Selitsky SR, et al. Transcriptomic analysis of chronic hepatitis B and C and liver cancer reveals microRNA-mediated control of cholesterol synthesis programs. MBio. 2015;6(6):e01500\u201315.","journal-title":"MBio"},{"issue":"15","key":"1250_CR79","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.3748\/wjg.v21.i15.4517","volume":"21","author":"M Li","year":"2015","unstructured":"Li M, et al. MicroRNA-185-5p mediates regulation of SREBP2 expression by hepatitis C virus core protein. World J gastroenterology: WJG. 2015;21(15):4517.","journal-title":"World J gastroenterology: WJG"},{"key":"1250_CR80","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s10096-016-2851-1","volume":"36","author":"M Sidorkiewicz","year":"2017","unstructured":"Sidorkiewicz M, et al. The impact of chronic hepatitis C infection on cholesterol metabolism in PBMCs is associated with microRNA-146a expression. Eur J Clin Microbiol Infect Dis. 2017;36:697\u2013702.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1250_CR81","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.phrs.2013.03.004","volume":"75","author":"PA Thibault","year":"2013","unstructured":"Thibault PA, Wilson JA. Targeting miRNAs to treat hepatitis C virus infections and liver pathology: inhibiting the virus and altering the host. Pharmacol Res. 2013;75:48\u201359.","journal-title":"Pharmacol Res"},{"issue":"5","key":"1250_CR82","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1093\/nar\/gkad094","volume":"51","author":"M Rheault","year":"2023","unstructured":"Rheault M, et al. Elucidating the distinct contributions of miR-122 in the HCV life cycle reveals insights into virion assembly. Nucleic Acids Res. 2023;51(5):2447\u201363.","journal-title":"Nucleic Acids Res"},{"key":"1250_CR83","doi-asserted-by":"crossref","unstructured":"Sidorkiewicz M, Grek-Kowalinska M, Piekarska A. Changes in miR-122 and cholesterol expression in Chronic Hepatitis C Patients after PegIFN-Alpha\/Ribavirin treatment. Pathogens. 2020;9(6):514.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7350302\/.","DOI":"10.3390\/pathogens9060514"},{"issue":"4","key":"1250_CR84","first-page":"293","volume":"4","author":"MM Mahdy","year":"2016","unstructured":"Mahdy MM, et al. miR-29a promotes lipid droplet and triglyceride formation in HCV infection by inducing expression of SREBP-1c and CaV1. J Clin Translational Hepatol. 2016;4(4):293.","journal-title":"J Clin Translational Hepatol"},{"key":"1250_CR85","doi-asserted-by":"crossref","unstructured":"M Cui. Involvement of cholesterol in hepatitis B virus X protein-induced abnormal lipid metabolism of hepatoma cells via up-regulating miR-205-targeted ACSL4. Biochem Biophys Res Comm. 2014;(3):651\u20135.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/24576478\/.","DOI":"10.1016\/j.bbrc.2014.02.068"},{"issue":"2","key":"1250_CR86","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmet.2006.01.005","volume":"3","author":"C Esau","year":"2006","unstructured":"Esau C, et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metabol. 2006;3(2):87\u201398.","journal-title":"Cell Metabol"},{"issue":"2","key":"1250_CR87","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jhep.2014.10.004","volume":"62","author":"S Bandiera","year":"2015","unstructured":"Bandiera S, et al. miR-122\u2013a key factor and therapeutic target in liver disease. J Hepatol. 2015;62(2):448\u201357.","journal-title":"J Hepatol"},{"issue":"4","key":"1250_CR88","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1053\/j.gastro.2007.08.002","volume":"133","author":"Y Shan","year":"2007","unstructured":"Shan Y, et al. Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes. Gastroenterology. 2007;133(4):1166\u201374.","journal-title":"Gastroenterology"},{"issue":"10","key":"1250_CR89","doi-asserted-by":"crossref","first-page":"6578","DOI":"10.1093\/nar\/gku260","volume":"42","author":"X Dai","year":"2014","unstructured":"Dai X, et al. Modulation of HBV replication by microRNA-15b through targeting hepatocyte nuclear factor 1\u03b1. Nucleic Acids Res. 2014;42(10):6578\u201390.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"1250_CR90","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3390\/ijms9060978","volume":"9","author":"Z Liu","year":"2008","unstructured":"Liu Z, Sall A, Yang D. MicroRNA: an emerging therapeutic target and intervention tool. Int J Mol Sci. 2008;9(6):978\u201399.","journal-title":"Int J Mol Sci"},{"key":"1250_CR91","doi-asserted-by":"crossref","unstructured":"Ghosh Z, Mallick B, Chakrabarti J. Cellular versus viral microRNAs in host\u2013virus interaction. Nucleic Acids Res. 2009;37(4):1035\u201348.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2651794\/.","DOI":"10.1093\/nar\/gkn1004"},{"issue":"12","key":"1250_CR92","doi-asserted-by":"crossref","first-page":"e1003018","DOI":"10.1371\/journal.ppat.1003018","volume":"8","author":"RP Kincaid","year":"2012","unstructured":"Kincaid RP, Sullivan CS. Virus-encoded microRNAs: an overview and a look to the future. PLoS Pathog. 2012;8(12):e1003018.","journal-title":"PLoS Pathog"},{"issue":"18","key":"1250_CR93","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","volume":"368","author":"HL Janssen","year":"2013","unstructured":"Janssen HL, et al. Treatment of HCV infection by targeting microRNA. N Engl J Med. 2013;368(18):1685\u201394.","journal-title":"N Engl J Med"},{"issue":"10070","key":"1250_CR94","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(16)31715-9","volume":"389","author":"MH van der Ree","year":"2017","unstructured":"van der Ree MH, et al. Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial. The Lancet. 2017;389(10070):709\u201317.","journal-title":"The Lancet"},{"key":"1250_CR95","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3389\/fgene.2018.00439","volume":"9","author":"E Girardi","year":"2018","unstructured":"Girardi E, L\u00f3pez P, Pfeffer S. On the importance of host microRNAs during viral infection. Front Genet. 2018;9:439.","journal-title":"Front Genet"},{"issue":"3","key":"1250_CR96","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3390\/antibiotics11030356","volume":"11","author":"\u00c1 Mourenza","year":"2022","unstructured":"Mourenza \u00c1, et al. Understanding microRNAs in the context of infection to find New Treatments against Human bacterial pathogens. Antibiotics. 2022;11(3):356.","journal-title":"Antibiotics"},{"key":"1250_CR97","doi-asserted-by":"crossref","unstructured":"Dash S, Dash C, Pandhare J. Therapeutic significance of microRNA-mediated regulation of PARP-1 in SARS-CoV-2 infection Non-coding RNA, 2021. 7(4): p. 60.","DOI":"10.3390\/ncrna7040060"},{"key":"1250_CR98","doi-asserted-by":"crossref","unstructured":"Yasamineh S et al. A state-of-the-art review on the recent advances of niosomes as a targeted drug delivery system. Int J Pharm, 2022: p. 121878.","DOI":"10.1016\/j.ijpharm.2022.121878"},{"issue":"1","key":"1250_CR99","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.gpb.2015.02.001","volume":"13","author":"J Zhang","year":"2015","unstructured":"Zhang J, et al. Exosome and exosomal microRNA: trafficking, sorting, and function. Genom Proteom Bioinform. 2015;13(1):17\u201324.","journal-title":"Genom Proteom Bioinform"}],"updated-by":[{"DOI":"10.1186\/s12964-023-01325-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000}}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-023-01250-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-023-01250-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-023-01250-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T05:31:29Z","timestamp":1700285489000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-023-01250-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,14]]},"references-count":99,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1250"],"URL":"https:\/\/doi.org\/10.1186\/s12964-023-01250-w","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12964-023-01325-8","asserted-by":"object"}]},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,14]]},"assertion":[{"value":"20 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12964-023-01325-8","URL":"https:\/\/doi.org\/10.1186\/s12964-023-01325-8","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors have Consented to the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"231"}}